Article
FDA multicenter trial confirms CK safety, efficacy for hyperopia
Anaheim, CA-Conductive keratoplasty (CK), a thermokeratoplasty technique used to reshape the cornea, appears to be a safe and effective approach for treating low to moderate hyperopia with little or no induced astigmatism, according to Marguerite B. McDonald, MD, medical monitor of the FDA multicenter trial.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
